Articles
-
Quality Standards
9/3/2025
Learn how our Quality Management System (QMS) can accelerate your project’s path to market and enable the development, manufacture, and delivery of safe and effective products.
-
Keep A Close Eye On Quality With Excipients For Drug Formulation
8/27/2025
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Addressing Your Requirements For Parenteral Applications
8/27/2025
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Solve Complex Small Molecule Challenges
8/21/2025
We specialize in the custom development and manufacturing of small molecule APIs, intermediates, and RSMs, offering scalable solutions from kilograms to multi-ton quantities.
-
Increasing Batch Size And Reducing Cycle Times For A Biologic
8/5/2025
JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
-
AI Predictive Maintenance Prevents Batch Loss And Production Shutdown
8/5/2025
AI-powered predictive maintenance with wireless vibration sensors prevented costly batch loss and production shutdowns in pharma manufacturing by detecting and fixing equipment issues before failures occurred.
-
Comprehensive Manufacturing Solutions Backed By Global Expertise
8/4/2025
Gain insight into a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance that can support your company's needs.
-
Improving Efficiency In Contamination Identification
7/11/2025
Discover how rapid microbial identification using MALDI-TOF improves contamination response, shortens investigation timelines, and enhances efficiency in biopharmaceutical manufacturing.
-
Key Considerations For Peptide And Oligonucleotide CDMO Selection
7/11/2025
Amid this new era of peptide and oligonucleotide therapeutics, sponsors are facing an increasingly competitive climate. To mitigate this, CDMOs are building out their in-house capacity and increasing their analytical capabilities. For emerging peptide and oligonucleotide sponsors, the key is identifying an experienced partner early.
-
SMB Technology: Optimizing API Purification
6/13/2025
Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.